738569-47-6Relevant academic research and scientific papers
TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE
-
Paragraph 0808; 0809, (2016/12/22)
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
